Teresa Brophy Bair

Companies

• Kura OncologyGeneral counsel Oct 19, 2021 to now¹
• Athenex, Inc.General counsel Jun 23, 2020 to Aug 5, 2021²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• KOKura Oncology KURA187,002 shares³$1.7M at $9.21Sep 28, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 28, 2026Sold 8,442 shares at $10.50 of Kura Oncology³
• Aug 19, 2026Sold 31,487 shares at $12.63 of Kura Oncology⁴
• May 18, 2026Sold 2,256 shares at $9.38 of Kura Oncology⁵
• Jan 27, 2026Sold 4,777 shares at $8.46 of Kura Oncology⁶
• Jan 27, 2026Sold 2,335 shares at $8.46 of Kura Oncology⁶
• Jan 27, 2026Sold 4,096 shares at $8.46 of Kura Oncology⁶
• Jan 2, 2026Granted 50,000 shares of Kura Oncology⁷
• Nov 14, 2025Sold 8,804 shares at $11.18 of Kura Oncology⁸
• Nov 13, 2025Granted 48,900 shares of Kura Oncology⁸
• Sep 29, 2025Sold 8,805 shares at $8.94 of Kura Oncology⁹
• Sep 27, 2025Granted 48,900 shares of Kura Oncology⁹
• May 19, 2025Sold 1,559 shares at $5.96 of Kura Oncology¹⁰
• Jan 28, 2025Sold 4,844 shares at $7.87 of Kura Oncology¹¹
• Jan 28, 2025Sold 2,437 shares at $7.87 of Kura Oncology¹¹
• Jan 2, 2025Granted 46,250 shares of Kura Oncology¹²
• May 20, 2024Sold 2,615 shares at $22.15 of Kura Oncology¹³
• Jan 29, 2024Sold 2,053 shares at $17.80 of Kura Oncology¹⁴
• Jan 2, 2024Granted 46,250 shares of Kura Oncology¹⁵
• Feb 16, 2023Granted 23,125 shares of Kura Oncology¹⁶
• Nov 17, 2022Sold 2,100 shares at $15.22 of Kura Oncology¹⁷